At Heally, our clinicians can help you start Mounjaro safely, monitor your progress, and create a tailored plan for sustainable, long-term weight loss. Schedule a free consultation with Heally to connect with licensed healthcare professionals who can guide your Mounjaro lifestyle and plan for safe, sustained success.
Sources
- FDA – Access Data: MOUNJARO (tirzepatide) injection, for subcutaneous use – Full Prescribing Information
- NCBI – StatPearls: Tirzepatide
- Nature Medicine: Tirzepatide Once Weekly for the Treatment of Obesity
- Diabetes Therapy: Impact of Morning vs. Evening Administration of Once-Weekly Tirzepatide on Glucose Control and Body Weight in Patients with Type 2 Diabetes
- Frontiers in Endocrinology: Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- GoodRx: How to Use Mounjaro (Tirzepatide) Pen Injector
- Journal of Diabetes Investigation: Patient Preferences and Perceptions on Injection Timing for Once-Weekly GLP-1 Receptor Agonists: A Cross-Sectional Survey
- ScienceDirect / Peptides: The Role of Circadian Rhythms in the Efficacy and Side Effects of GLP-1 Receptor Agonists
Important Medical Information and Disclaimers
Important Current Status Update: On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide. Pharmacies may no longer legally compound tirzepatide in most cases, since the FDA confirmed that no drug shortage exists. Patients should use FDA-approved medications like Mounjaro® and Zepbound® unless a provider confirms a medical necessity. Compounding pharmacies do not receive FDA approval for their medications and may introduce different risks compared to FDA-approved drugs.
Medical Disclaimer:
This content is for informational purposes only and is not a substitute for professional medical advice. Tirzepatide is FDA-approved as Mounjaro® for type 2 diabetes and Zepbound® for chronic weight management. Always consult a qualified healthcare provider before starting or changing any treatment.
Individual Results May Vary:
Responses to tirzepatide treatment differ from person to person. Factors such as adherence, lifestyle, metabolism, and underlying health conditions all play a role in treatment outcomes.
Important Safety Information:
- Common side effects may include nausea, vomiting, diarrhea, decreased appetite, constipation, stomach pain, and injection site reactions.
- Serious side effects can occur, including pancreatitis, gallbladder or kidney problems, and severe allergic reactions.
- Always share your complete medical history with your healthcare provider before beginning treatment.
FDA Adverse Event Reporting:
Report any side effects from prescription medications to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.
